WallStSmart
SVRA

Savara Inc

NASDAQ: SVRA · HEALTHCARE · BIOTECHNOLOGY

$5.12
-2.10% today

Updated 2026-05-11

Market cap
$1.06B
P/E ratio
P/S ratio
145,272.62x
EPS (TTM)
$-0.53
Dividend yield
52W range
$2 – $7
Volume
1.5M

Savara Inc (SVRA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-15.77M$-19.64M$-23.79M$-12.62M$-8.34M$-13.47M$-13.92M$-17.79M$-24.64M$-32.95M$-8.37M$-28.23M$-39.27M$-45.12M$-39.84M$-40.08M$-34.55M$-51.06M$-89.09M$-101.04M
Capital expenditures$172112.00$127259.00$64955.00$0.00$28513.00$411762.00$266175.00$46781.00$147000.00$165000.00$8000.00$495000.00$141000.00$148000.00$3.29M$57000.00$9000.00$296000.00$25000.00$22000.00
Depreciation$176688.00$197783.00$168039.00$79728.00$19821.00$37570.00$90047.00$39517.00$85000.00$146000.00$346000.00$363000.00$526000.00$1.01M$693000.00$367000.00$167000.00$77000.00$130000.00
Stock-based comp$1.61M$585437.00$785943.00$866052.00$1.46M$1.60M$2.03M$2.67M$209000.00$552000.00$3.74M$4.44M$5.11M$3.26M$2.04M$4.18M$9.86M$14.42M
Free cash flow$-15.95M$-19.77M$-23.85M$-12.62M$-8.37M$-13.88M$-14.19M$-17.84M$-24.79M$-33.11M$-8.38M$-28.73M$-39.42M$-45.27M$-43.13M$-40.14M$-34.56M$-51.36M$-89.11M$-101.06M
Investing cash flow$-17.77M$8.01M$18.86M$16000.00$-24134.00$-7.54M$-7.17M$-4.77M$481000.00$3.40M$-8000.00$-69.11M$-13.62M$15.74M$9.05M$-69.46M$52.65M$-57.12M$-39.94M
Financing cash flow$44.89M$441616.00$11.42M$27.68M$36.60M$740.00$25.74M$34.29M$16.80M$5.12M$106.09M$55.19M$54.91M$3.69M$120.81M$87000.00$82.78M$117.58M
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.12M
Share repurchases
Debt repayment
Net change in cash$15.59M$-21.07M$3.18M$10.13M$-12.76M$-14.51M$8.75M$2.30M$25.52M$-27.09M